Finally, we performed a xenograft experiment and in vitro angiogenesis assays, and found that sh-circASH2L inhibited tumor growth, VEGFA-mediated angiogenesis, and lymphangiogenesis in vivo and in vitro. Here, VEGFA is linked to neoplasm.